2024年10月22日

Mayer Brown advises SERB Pharmaceuticals on the structuring of the acquisition of Aurlumyn®

Mayer Brown advised SERB Pharmaceuticals, a global specialty pharmaceutical company, on the structuring of the acquisition of Aurlumyn ®(iloprost IV), the only FDA approved treatment option for severe frostbite in the US, from CiVi Biopharma.

 

 

Mayer Brown is a global legal services provider comprising associated legal practices that are separate entities, including Mayer Brown LLP (Illinois, USA), Mayer Brown International LLP (England & Wales), Mayer Brown Hong Kong LLP (a Hong Kong limited liability partnership) and Tauil & Chequer Advogados (a Brazilian law partnership) (collectively, the “Mayer Brown Practices”). The Mayer Brown Practices are established in various jurisdictions and may be a legal person or a partnership. PK Wong & Nair LLC (“PKWN”) is the constituent Singapore law practice of our licensed joint law venture in Singapore, Mayer Brown PK Wong & Nair Pte. Ltd. Mayer Brown Hong Kong LLP operates in temporary association with Johnson Stokes & Master (“JSM”). More information about the individual Mayer Brown Practices, PKWN and the association between Mayer Brown Hong Kong LLP and JSM (including how information may be shared) can be found in the Legal Notices section of our website.

“Mayer Brown” and the Mayer Brown logo are trademarks of Mayer Brown.

Attorney Advertising. Prior results do not guarantee a similar outcome.